$28M Daraprim Third-Party Antitrust Class Settlement Gets Final Approval
NEW YORK — A New York federal judge on June 17 entered final judgment and an order of dismissal for a $28 million antitrust settlement for third-party payers who bought overpriced...To view the full article, register now.
Already a subscriber? Click here to view full article